Hypertonic saline releases the attached small intestinal cystic fibrosis mucus

Clinical and Experimental Pharmacology and Physiology

Volumn 42, Issue 1, 2015, Pages 69-75

  Ermund, Anna ^a   Meiss, Lauren N ^a   Scholte, Bob J ^b   Hansson, Gunnar C ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cystic fibrosis; Hypertonic saline solution; Ileum; Mucin; Mucus

Indexed keywords

BICARBONATE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; MUCIN; MUCOLYTIC AGENT; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; EXPLANT; FEMALE; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; LUNG DISEASE; MALE; MEASUREMENT; MOUSE; MUCUS; NONHUMAN; SMALL INTESTINE; THICKNESS; ANIMAL; C57BL MOUSE; DRUG EFFECTS; ORGAN CULTURE TECHNIQUE; PATHOLOGY; SECRETION (PROCESS); TRANSGENIC MOUSE;

ANIMALS; CYSTIC FIBROSIS; FEMALE; INTESTINE, SMALL; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUCUS; ORGAN CULTURE TECHNIQUES; SALINE SOLUTION, HYPERTONIC;

EID: 84919665852     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12322     Document Type: Article

References (27)

1. Riordan JR, Rommens JM, Kerem BS et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 1989; 245: 1066-73.
2. Riordan JR. Assembly of functional CFTR chloride channels. Ann. Rev. Physiol. 2005; 67: 701-18.
3. Quinton PM. Cystic fibrosis: Impaired bicarbonate secretion and mucoviscidosis. Lancet 2008; 372: 415-7.
4. Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N. Engl. J. Med. 2005; 352: 1992-2001.
5. Hoffman LR, Ramsey BW. Cystic fibrosis therapeutics: The road ahead. Chest 2013; 143: 207-13.
6. Gustafsson JK, Ermund A, Ambort D et al. Bicarbonate and functional CFTR channel is required for proper mucin secretion and link cystic fibrosis with its mucus phenotype. J. Exp. Med. 2012; 209: 1263-72.
7. Ramsey BW, Davies J, McElvaney NG et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N. Engl. J. Med. 2011; 365: 1663-72.
8. O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009; 373: 1891-904.
9. Wark P, McDonald VM. Nebulised hypertonic saline for cystic fibrosis. Cochrane Database Syst. Rev. 2009; (2): CD001506.
10. Riedler J, Reade T, Button B, Robertson CF. Inhaled hypertonic saline increases sputum expectoration in cystic fibrosis. J. Paediatr. Child Health 1996; 32: 48-50.
11. Wills PJ, Hall RL, Chan WM, Cole PJ. Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea. J. Clin. Invest. 1997; 99: 9-13.
12. King M, Dasgupta B, Tomkiewicz RP, Brown NE. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease. Am. J. Respir. Crit. Care Med. 1997; 156: 173-7.
13. Wilke M, Buijs-Offerman RM, Aarbiou J et al. Mouse models of cystic fibrosis: Phenotypic analysis and research applications. J. Cyst. Fibros. 2011; 10(Suppl. 2): S152-71.
14. Ambort D, Johansson MEV, Gustafsson JK et al. Calcium and pH-dependent packing and release of the Gel-forming MUC2 mucin. Proc. Natl Acad. Sci. USA 2012; 109: 5645-50.
15. Ermund A, Schutte A, Johansson MEV, Gustafsson JK, Hansson GC. Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches. Am. J. Physiol. Gastroint. Liver Physiol. 2013; 305: G341-7.
16. Gustafsson JK, Ermund A, Johansson MEV, Schutte A, Hansson GC, Sjovall H. An ex vivo method for studying mucus formation, properties and thickness in human colonic biopsies and mouse small and large intestinal explants. Am. J. Physiol. Gastrointest. Liver Physiol. 2012; 302: G430-8.
17. Burness CB, Keating GM. Mannitol dry powder for inhalation: In patients with cystic fibrosis. Drugs 2012; 72: 1411-21.
18. Pezzulo AA, Tang XX, Hoegger MJ et al. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 2012; 487: 109-13.
19. Matsui H, Grubb BR, Tarran R et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998; 95: 1005-15.
20. + absorption produces cystic fibrosis-like lung disease in mice. Nat. Med. 2004; 10: 487-93.
21. Button B, Cai LH, Ehre C et al. A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science 2012; 337: 937-41.
22. Kesimer M, Ehre C, Burns KA, Davis CW, Sheehan JK, Pickles RJ. Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways. Mucosal Immunol. 2012; 6: 379-92.
23. Hoegger MJ, Fischer AJ, McMenimen JD et al. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis. Science 2014; 345: 818-22.
24. Robinson M, Daviskas E, Eberl S et al. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: A pilot study. Eur. Respir. J. 1999; 14: 678-85.
25. van Doorninck JH, French PJ, Verbeek E et al. A mouse model for the cystic fibrosis Delta F508 mutation. EMBO J. 1995; 14: 4403-11.
26. French PJ, vanDoorninck JH, Peters RHPC et al. A Delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo. J. Clin. Invest. 1996; 98: 1304-12.
27. Johansson MEV, Phillipson M, Petersson J, Holm L, Velcich A, Hansson GC. The inner of the two Muc2 mucin dependent mucus layers in colon is devoid of bacteria. Proc. Natl Acad. Sci. USA 2008; 105: 15064-9.